查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球呼吸道合胞病毒診斷市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測
市場調查報告書
商品編碼
1377881

全球呼吸道合胞病毒診斷市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

Global Respiratory Syncytial Virus Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 157 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2030 年，全球呼吸道合胞病毒診斷市場的市場規模將從 2022 年的 998.2 萬美元達到近 2,171.05 萬美元，在 2023 年至 2030 年的研究期間CAGR為 10.2%。

呼吸道合胞病毒 (RSV) 診斷是指用於檢測和識別呼吸道合胞病毒（一種主要影響呼吸系統的常見病毒病原體）的各種測試和方法。該病毒是嬰兒、幼兒和老年人呼吸道感染的主要原因，可導致從輕度感冒樣症狀到嚴重呼吸道疾病的病症，尤其是在弱勢群體中。準確、及時的 RSV 診斷對於適當的患者管理和感染控制至關重要。

市場動態：

呼吸道合胞病毒 (RSV) 診斷市場正在幾個關鍵因素的推動下成長。 RSV 是一種常見的呼吸道病毒，可導致嚴重疾病，尤其是嬰兒、老年人和免疫系統較弱的人。這種流行，加上季節性爆發，強調了準確和及時診斷的必要性。診斷技術的進步，包括 PCR 和即時檢測 (POCT) 等分子檢測，提高了 RSV 檢測的靈敏度和速度，使診斷更加高效和方便。快速 POCT 的可用性在臨床環境中特別有價值，可以減少對複雜實驗室檢測的依賴。人們（尤其是醫療保健專業人員）對 RSV 影響的認知不斷提高，促使人們更多地考慮 RSV 檢測，特別是在兒科和老年護理領域。公共衛生準備和監測也依賴 RSV 診斷來追蹤和應對疫情。此外，全球人口老化和旅行全球化增加了各個地區嚴重 RSV 感染的風險，進一步推動了對診斷的需求。隨著創新診斷技術的不斷發展以及人們對 RSV 嚴重性的認知不斷增強，RSV 診斷市場預計將進一步擴大，確保及早識別和干涉這種重要的呼吸道病毒。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球呼吸道合胞病毒診斷市場的每個細分市場進行了包容性評估。呼吸道合胞病毒診斷產業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲呼吸道合胞病毒診斷市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。呼吸道合胞病毒診斷市場的主要參與者包括 Becton、Dickinson, and Company、Novartis AG、Abbott、Ortho Clinical Diagnostics、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories, Inc.、F. Hoffmann-La Roche Ltd.、 BIOMERIEUX、DiaSorin SpA、Merck KGaA、Quidel Corp.、Coris BioConcept、Siemens Healthcare SA、Quest Diagnostics Inc. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：呼吸道合胞病毒診斷 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球呼吸道合胞病毒診斷市場分析：按產品

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 直接螢光抗體 (Dfa) 法
  • 快速抗原診斷測試 (Radt)
  • 分子診斷
  • 色譜免疫分析（重力驅動測試，Oligo 色譜 (Oc)）
  • 診斷影像
  • 凝膠微滴
  • 流式細胞儀
  • 其他

第 6 章：全球呼吸道合胞病毒診斷市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 醫院
  • 實驗室
  • 診所
  • 居家護理

第 7 章：全球呼吸道合胞病毒診斷市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：呼吸道合胞病毒診斷公司的競爭格局

  • 呼吸道合胞病毒診斷市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Becton
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Dickinson and Company
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Novartis AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Abbott
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Ortho Clinical Diagnostics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bio-Rad Laboratories Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • F. Hoffmann-La Roche Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BIOMERIEUX
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • DiaSorin SpA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck KGaA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Quidel Corp.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Coris BioConcept
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Siemens Healthcare SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Quest Diagnostics Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112112234

The global demand for Respiratory Syncytial Virus Diagnostics Market is presumed to reach the market size of nearly USD 2171.05 MN by 2030 from USD 998.2 MN in 2022 with a CAGR of 10.2% under the study period 2023 - 2030.

Respiratory syncytial virus (RSV) diagnostics refer to the various tests and methods used to detect and identify respiratory syncytial virus, a common viral pathogen that primarily affects the respiratory system. The virus is a major cause of respiratory tract infections in infants, young children, and older adults, and it can lead to conditions ranging from mild cold-like symptoms to severe respiratory illness, especially in vulnerable populations. Accurate and timely diagnosis of RSV is crucial for appropriate patient management and infection control.

MARKET DYNAMICS:

The Respiratory Syncytial Virus (RSV) diagnostics market is experiencing growth driven by several key factors. RSV is a prevalent respiratory virus that can cause severe illness, particularly in infants, the elderly, and individuals with weakened immune systems. This prevalence, coupled with seasonal outbreaks, underscores the need for accurate and timely diagnostics. Advancements in diagnostic technology, including molecular assays like PCR and point-of-care testing (POCT), have enhanced the sensitivity and speed of RSV detection, making diagnostics more efficient and accessible. The availability of rapid POCTs is particularly valuable in clinical settings, reducing the reliance on complex laboratory testing. Increased awareness of RSV's impact, especially among healthcare professionals, has contributed to greater consideration of RSV testing, particularly in pediatric and geriatric care. Public health preparedness and surveillance also rely on RSV diagnostics to track and respond to outbreaks. Additionally, the aging global population and the globalization of travel have raised the risk of severe RSV infections in various regions, further driving the demand for diagnostics. As innovative diagnostic technologies continue to develop and awareness of RSV's severity grows, the market for RSV diagnostics is expected to expand further, ensuring early identification and intervention for this significant respiratory virus.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of respiratory syncytial virus diagnostics. The growth and trends of respiratory syncytial virus diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the respiratory syncytial virus diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Direct Fluorescent Antibody (Dfa) Method
  • Rapid Antigen Diagnostic Test (Radt)
  • Molecular Diagnostics
  • Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc))
  • Diagnostic Imaging
  • Gel Microdroplets
  • Flow Cytometry
  • Others

By End-Use

  • Hospitals
  • Laboratory
  • Clinics
  • Homecare

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Respiratory Syncytial Virus Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Respiratory Syncytial Virus Diagnostics market include Becton, Dickinson, and Company, Novartis AG, Abbott, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., BIOMERIEUX, DiaSorin SpA, Merck KGaA, Quidel Corp., Coris BioConcept, Siemens Healthcare SA, Quest Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Direct Fluorescent Antibody (Dfa) Method Historic and Forecast Sales by Regions
  • 5.5 Rapid Antigen Diagnostic Test (Radt) Historic and Forecast Sales by Regions
  • 5.6 Molecular Diagnostics Historic and Forecast Sales by Regions
  • 5.7 Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc)) Historic and Forecast Sales by Regions
  • 5.8 Diagnostic Imaging Historic and Forecast Sales by Regions
  • 5.9 Gel Microdroplets Historic and Forecast Sales by Regions
  • 5.10. Flow Cytometry Historic and Forecast Sales by Regions
  • 5.11 Others Historic and Forecast Sales by Regions

6 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY END-USE

  • 6.1 Overview by End-Use
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-Use
  • 6.4 Hospitals Historic and Forecast Sales by Regions
  • 6.5 Laboratory Historic and Forecast Sales by Regions
  • 6.6 Clinics Historic and Forecast Sales by Regions
  • 6.7 Homecare Historic and Forecast Sales by Regions

7 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS COMPANIES

  • 8.1. Respiratory Syncytial Virus Diagnostics Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Becton
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Dickinson and Company
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Novartis AG
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Abbott
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Ortho Clinical Diagnostics
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Thermo Fisher Scientific Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Bio-Rad Laboratories Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. F. Hoffmann-La Roche Ltd.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. BIOMERIEUX
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. DiaSorin SpA
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Merck KGaA
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Quidel Corp.
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. Coris BioConcept
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. Siemens Healthcare SA
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. Quest Diagnostics Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Direct Fluorescent Antibody (Dfa) Method Market Sales by Geography (USD MN)
  • Rapid Antigen Diagnostic Test (Radt) Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc)) Market Sales by Geography (USD MN)
  • Diagnostic Imaging Market Sales by Geography (USD MN)
  • Gel Microdroplets Market Sales by Geography (USD MN)
  • Flow Cytometry Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-Use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Homecare Market Sales by Geography (USD MN)
  • Global Respiratory Syncytial Virus Diagnostics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Respiratory Syncytial Virus Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Respiratory Syncytial Virus Diagnostics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Direct Fluorescent Antibody (Dfa) Method Market Sales by Geography (USD MN)
  • Rapid Antigen Diagnostic Test (Radt) Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc)) Market Sales by Geography (USD MN)
  • Diagnostic Imaging Market Sales by Geography (USD MN)
  • Gel Microdroplets Market Sales by Geography (USD MN)
  • Flow Cytometry Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Homecare Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.